Scientists pinpoint the cause of a rare childhood seizure disorder

Early Infantile Epileptic Encephalopathy (EIEE) is a rare disease that causes intractable seizures within the first few months of life. Over 50 genes have been linked to EIEE, meaning the condition is difficult to diagnose.

Now, bioinformatics experts from the University of Utah Health have created a set of high-tech, computational tools that can pinpoint the cause of the condition.

Child with Early Infantile Epileptic Encephalopathy (EIEE)Image Credit: By Mama Belle Love kids

If EIEE is not diagnosed and treated early on, the seizures can interrupt normal development and lead to early death.

Researchers have identified 50 genes linked to EIEE, but standard genetic testing often fails to detect the cause of the disease, meaning treatment approaches are limited to managing a child’s symptoms.

Now, rather than undergoing multiple tests, the new tools could be used to deliver results quickly and ultimately at a lower cost, says senior author Aaron Quinlan: "These tools let us peek in the dark corners and under the rug of the genome that other methods do not."

As reported in the journal Nature Genomic Medicine, Quinlan and colleagues developed a suite of computational tools that used algorithms to assess the genome of 14 patients and their parents, to pinpoint the genomic abnormalities that lead to EIEE.

The technique led the researchers to a spontaneous mutation that caused EIEE in 12 of the 14 patients.

In one patient, the mutation was located on a gene that had not previously been linked to EIEE.

In the remaining two patients, the team identified significant structural changes that affected genes already known to be linked to EIEE, but that were not identifiable using routine genetic testing.

These families have been drifting through expensive prolonged testing with little hope of finding an answer. We can now identify the genetic cause of EIEE and select medications best suited to each patient to decrease the frequency of seizures earlier and hopefully prevent developmental delays."

Betsy Ostrander, First Author

The tools that were developed for the study are now available to researchers on the USTAR Center for Genetic Discovery website.

Sally Robertson

Written by

Sally Robertson

Sally first developed an interest in medical communications when she took on the role of Journal Development Editor for BioMed Central (BMC), after having graduated with a degree in biomedical science from Greenwich University.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Robertson, Sally. (2023, July 18). Scientists pinpoint the cause of a rare childhood seizure disorder. News-Medical. Retrieved on November 17, 2024 from https://www.news-medical.net/news/20180813/Scientists-pinpoint-the-cause-of-rare-childhood-seizure-disorder.aspx.

  • MLA

    Robertson, Sally. "Scientists pinpoint the cause of a rare childhood seizure disorder". News-Medical. 17 November 2024. <https://www.news-medical.net/news/20180813/Scientists-pinpoint-the-cause-of-rare-childhood-seizure-disorder.aspx>.

  • Chicago

    Robertson, Sally. "Scientists pinpoint the cause of a rare childhood seizure disorder". News-Medical. https://www.news-medical.net/news/20180813/Scientists-pinpoint-the-cause-of-rare-childhood-seizure-disorder.aspx. (accessed November 17, 2024).

  • Harvard

    Robertson, Sally. 2023. Scientists pinpoint the cause of a rare childhood seizure disorder. News-Medical, viewed 17 November 2024, https://www.news-medical.net/news/20180813/Scientists-pinpoint-the-cause-of-rare-childhood-seizure-disorder.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.